ClinicalTrials.gg
RecruitingNCT04889872PROGRESSUpdated Dec 17, 2025

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

An interventional study of SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA in Aortic Stenosis, Calcific and Aortic Valve Stenosis, sponsored by Edwards Lifesciences. Recruiting at 80 sites in 6 countries. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-12-17.

Sponsored by Edwards Lifesciences · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2021; still recruiting 5 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,250
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis.

Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

Read the detailed description

This is a prospective, randomized, controlled, multicenter study. Subjects will be randomized to either transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 / SAPIEN 3 Ultra /SAPIEN 3 Ultra RESILIA THV or Clinical Surveillance.

02

Conditions studied

  • Aortic Stenosis, Calcific
  • Aortic Valve Stenosis

Keywords

  • Transcatheter aortic valve replacement (TAVR)
  • SAPIEN 3
  • SAPIEN 3 Ultra
  • SAPIEN 3 Ultra RESILIA
  • Moderate aortic stenosis
  • Aortic stenosis
  • Transcatheter heart valve
03

In context

Aortic Valve, Calcification of

44 studies on the registry are indexed under Aortic Valve, Calcification of; 15 are open to participants now.

This study's planned enrollment of 2,250 is above the median of 100 across 23 interventional studies indexed under Aortic Valve, Calcification of.

Browse Aortic Valve, Calcification of studies →

Lead sponsor

Edwards Lifesciences is the lead sponsor of 128 studies on the registry; 17 are open to participants now.

Of its 35 completed or terminated interventional studies of FDA-regulated products, 33 (94%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Key Inclusion Criteria:

  1. 65 years of age or older at time of randomization
  2. Moderate aortic stenosis
  3. Subject has symptoms or evidence of cardiac damage/dysfunction
  4. The subject or subject's legal representative has been informed of the nature of the study, agrees to its provisions, and has provided written .

Key Exclusion Criteria:

  1. Native aortic annulus size unsuitable for the THV
  2. Anatomical characteristics that would preclude safe transfemoral placement of the introducer sheath or safe passage of the delivery system
  3. Aortic valve is unicuspid or non-calcified
  4. Bicuspid aortic valve with an aneurysmal ascending aorta > 4.5 cm or severe raphe/leaflet calcification
  5. Pre-existing mechanical or bioprosthetic aortic valve
  6. Severe aortic regurgitation
  7. Prior balloon aortic valvuloplasty to treat severe AS
  8. \< 20%
  9. Left ventricular outflow tract calcification that would increase the risk of annular rupture or significant paravalvular leak post-TAVR
  10. Cardiac imaging evidence of intracardiac mass, thrombus, or vegetation
  11. Coronary or aortic valve anatomy that increases the risk of coronary artery obstruction post-TAVR
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,250 participants (estimated)

Study arms

  • Experimental
    TAVR

    Transcatheter Aortic Valve Replacement (TAVR)

    Device: SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA

  • No intervention
    CS

    Clinical Surveillance (CS)

Interventions

  • DeviceSAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA

    Patients will be implanted with a SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA heart valve

06

What researchers measure

Primary outcomes

  1. Primary Effectiveness Endpoint

    Non-hierarchical composite of death, and heart failure hospitalization or event

    Time frame: 2 years

  2. Primary Safety Endpoint

    Non-hierarchical composite of death, stroke, life threatening or fatal bleeding, acute kidney injury stage 4, hospitalization due to device- or procedure-related complication, and valve dysfunction requiring reintervention

    Time frame: 30 days

Secondary outcomes

  1. Death, stroke, or heart failure hospitalization

    The number of patients that had this event

    Time frame: 2 years

  2. Alive and Kansas City Cardiomyopathy Questionnaire (KCCQ) score improvement ≥10 points from baseline sustained through 2 years

    The number of patients that met all these criteria

    Time frame: 2 years

  3. Heart failure hospitalization

    The number of patients that had this event

    Time frame: 2 years

  4. Left ventricle (LV) mass index

    Echocardiographic measurement of the size of the left ventricle

    Time frame: 2 years

  5. Diastolic dysfunction ≥ Grade 2

    Echocardiographic measurement of the stiffness of the left ventricle.

    Time frame: 2 years

07

Study locations

50 of 80 sites recruiting
  • Heart Center LLC, Huntsville
    Huntsville, Alabama 35801, United States
    Recruiting
  • Tucson Medical Center
    Tucson, Arizona 85712, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Cedars-Sinai Medical Center
    Los Angeles, California 90048, United States
    Recruiting
  • Huntington Hospital
    Pasadena, California 91105, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Eisenhower Desert Cardiology Center
    Rancho Mirage, California 92270, United States
    Recruiting
  • Bay Area Structural Heart at Sutter Health
    San Francisco, California 94109, United States
    Recruiting
  • Kaiser San Francisco Medical Center
    San Francisco, California 94118, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • University of California San Francisco
    San Francisco, California 94143, United States
    Recruiting
  • Santa Barbara Cottage Hospital
    Santa Barbara, California 93105, United States
    Recruiting
  • Stanford Univeristy
    Stanford, California 94305, United States
    Recruiting
  • UC Health Medical Center of the Rockies
    Loveland, Colorado 80538, United States
    Recruiting
  • Yale Universtiy
    New Haven, Connecticut 06510, United States
    Recruiting
  • The Cardiac & Vascular Institute Research Foundation
    Gainesville, Florida 32605, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Baptist Health Research Center
    Jacksonville, Florida 32207, United States
    Recruiting
  • Sarasota Memorial Health Care System
    Sarasota, Florida 34239, United States
    Recruiting
  • Emory University Atlanta
    Atlanta, Georgia 30308, United States
    Recruiting
  • Piedmont Heart Institute
    Atlanta, Georgia 30309, United States
    Recruiting
  • Saint Alphonsus
    Boise, Idaho 83704, United States
    Recruiting
  • Rush University Medical Center
    Chicago, Illinois 60612, United States
    Recruiting
  • Alexian Brothers Hospital
    Lisle, Illinois 60532, United States
    Recruiting
  • Ascension Via Christi St. Francis
    Wichita, Kansas 67226, United States
    Recruiting
  • Louisiana State University
    New Orleans, Louisiana 70112, United States
    Recruiting
  • Ochsner Clinical Foundation
    New Orleans, Louisiana 70121, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Massachusetts General Hospital Boston
    Boston, Massachusetts 02114, United States
    Recruiting
  • Minneapolis Heart Institue, St. Paul's
    Minneapolis, Minnesota 55102, United States
    Recruiting
  • CentraCare Heart and Vascular Center
    Saint Cloud, Minnesota 56303, United States
    Recruiting
  • Saint Luke's Hospital of Kansas City Mid America
    Kansas City, Missouri 64111, United States
    Recruiting
  • St. Patrick Hospital
    Missoula, Montana 59802, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Mary Hitchcock Memorial Hospital
    Lebanon, New Hampshire 03756, United States
    Recruiting
  • Atlantic Health System Hospital Corp - Morristown Medical Center
    Morristown, New Jersey 07960, United States
    Recruiting
  • Jersey Shore University Medical Center
    Neptune City, New Jersey 07753, United States
    Recruiting
  • Rutgers Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08901, United States
    Recruiting
  • The Valley Hospital
    Ridgewood, New Jersey 07450, United States
    Recruiting
  • University of Buffalo Kaleida Health
    Buffalo, New York 14203, United States
    Recruiting
  • NYU Langone Hospital - Long Island
    Mineola, New York 11501, United States
    Recruiting
  • NYU Langone Health
    New York, New York 10016, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Columbia University Irving Medical Center/NYPH
    New York, New York 10032, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Rochester General Hospital
    Rochester, New York 14621, United States
    Recruiting
  • St. Francis Hospital
    Roslyn, New York 11576, United States
    Recruiting
  • Montefiore Medical Center
    The Bronx, New York 10467, United States
    Recruiting
  • Moses Cone Memorial Hospital
    Greensboro, North Carolina 27401, United States
    Recruiting
  • The Christ Hospital
    Cincinnati, Ohio 45219, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Mount Carmel Health System
    Columbus, Ohio 43213, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Oklahoma Heart Institute
    Tulsa, Oklahoma 74104, United States
    Recruiting
  • Kaiser Permanente Northwest
    Clackamas, Oregon 97015, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Providence Heart & Vascular Institute Portland
    Portland, Oregon 97225, United States
    Withdrawn

    Not enrolling at this site — choose another above.

  • Legacy Emanuel Medical Center
    Portland, Oregon 97227, United States
    Recruiting
  • Allegheny Singer Research Institute
    Pittsburgh, Pennsylvania 15212, United States
    Recruiting
  • UPMC Presbyterian Shadyside
    Pittsburgh, Pennsylvania 15213, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Pinnacle Health Harrisburg
    Wormleysburg, Pennsylvania 17043, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Lankenau Medical Center
    Wynnewood, Pennsylvania 19096, United States
    Recruiting
  • Baptist Memorial Hospital Memphis
    Germantown, Tennessee 38138, United States
    Recruiting
  • Methodist Le Bonheur Healthcare
    Germantown, Tennessee 38138, United States
    Recruiting
  • Parkwest Medical Center
    Knoxville, Tennessee 37923, United States
    Recruiting
  • Saint Thomas Health
    Nashville, Tennessee 37205, United States
    Recruiting
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37232, United States
    Recruiting
  • Ascension Texas Cardiovascular
    Austin, Texas 78705, United States
    Recruiting
  • UT Southwestern Medical Center
    Dallas, Texas 75235, United States
    Recruiting
  • HCA Houston Healthcare Medical Center
    Houston, Texas 77004, United States
    Recruiting
  • The University of Texas Health Science Center
    Houston, Texas 77030, United States
    Recruiting
  • The Heart Hospital Baylor Plano
    Plano, Texas 75093, United States
    Recruiting
  • Methodist Hospital of San Antonio
    San Antonio, Texas 78229, United States
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Kaiser Mid Atlantic
    McLean, Virginia 22102, United States
    Recruiting
  • Sentara Norfolk General Hospital
    Norfolk, Virginia 23507, United States
    Recruiting
  • Swedish Medical Center
    Seattle, Washington 98112, United States
    Recruiting
  • The Prince Charles Hospital
    Chermside, Queensland 4032, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Royal Adelaide Hospital
    Adelaide, South Australia 5000, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Flinders Medical Centre
    Bedford Park, South Australia 5042, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Monash Health
    Clayton, Victoria 3168, Australia
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • St. Paul's Hospital
    Vancouver, British Columbia V6E1M7, Canada
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Hamiton Health Services
    Hamilton, Onterio L8L 2X2, Canada
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Kokura Memorial Hospital
    Fukuoka, Kyushu 802-8555, Japan
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Sendai Kousei Hospital
    Sendai, Miyagi 981-0914, Japan
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Sakakibara Heart Institute
    Fuchū, Tokyo 183-0003, Japan
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Keio University Hospital
    Shinjuku, Tokyo 160-8582, Japan
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • AMC Amsterdam
    Amsterdam, North Holland 1105 AZ, Netherlands
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Leiden Universitair Medisch Centrum
    Leiden, South Holland 2333, Netherlands
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Erasmus Rotterdam
    Rotterdam, South Holland 3015, Netherlands
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Hôpitaux Universitaire de Genève
    Geneva, 1205, Switzerland
    Active, not recruiting

    Not enrolling at this site — choose another above.

  • Universitätsspital Zürich
    Zurich, 8091, Switzerland
    Withdrawn

    Not enrolling at this site — choose another above.

08

References and documents

Publications

  • Genereux P, Makkar RR, Bax JJ, Pibarot P, Lindman BR, Prince H, Park B, Cohen DJ, Mack MJ, Leon MB. Design and rationale of the prospective, randomized, controlled trial to assess the management of moderate aortic stenosis by clinical surveillance or transcatheter aortic valve replacement: The PROGRESS Trial. Am Heart J. 2026 Jul;297:107433. doi: 10.1016/j.ahj.2026.107433. Epub 2026 Mar 25. PubMed 41895563 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2021 (actual). Primary completion is estimated for Jun 2029, 92 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 12, 2021
First posted
May 17, 2021
StartActual
Oct 12, 2021
Primary completionEst.
Jun 2029
CompletionEst.
Jun 2037
Last update
Dec 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04889872
Responsible party
Sponsor
First posted
May 17, 2021
Start date
Oct 12, 2021
Primary completion
Jun 2029 (estimated)
Completion
Jun 2037 (estimated)
Last update
Dec 17, 2025

Study contacts

Edwards THV Clinical Affairs
Contact
THV_CT.gov@Edwards.com
949-250-2500
Philippe Généreux, MD
principal investigator · Morristown Medical Center, Morristown, NJ, USA
Jeroen J Bax, MD, PhD
principal investigator · Leiden University Medical Center, Leiden, The Netherlands
Raj Makkar, MD
principal investigator · Cedars-Sinai Medical Center, Los Angeles, CA, USA

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion